Gibson, Anton, Chometon, Thaize Q, Damani, Tanvi et al. · Methods in molecular biology (Clifton, N.J.) · 2025 · DOI
Researchers developed a new laboratory technique to examine immune cells in the blood of ME/CFS patients in much greater detail than previously possible. Using advanced flow cytometry, they simultaneously measured over 40 different markers on individual immune cells, allowing them to create a detailed map of immune system abnormalities in ME/CFS. This technique is like upgrading from a simple photograph to a high-resolution image, revealing much more about how immune cells are behaving.
Developing better tools to measure immune abnormalities in ME/CFS is crucial for understanding disease mechanisms and identifying therapeutic targets. This advanced technique could enable researchers to identify specific immune cell dysfunctions that contribute to ME/CFS symptoms, potentially leading to better diagnostic tests and personalized treatments. The detailed characterization approach may help distinguish ME/CFS from other conditions with similar presentations.
This is a methods paper describing a technical approach; it does not establish that specific immune abnormalities cause ME/CFS symptoms or correlate with disease severity. The study does not provide clinical data, patient outcomes, or evidence that targeting identified immune abnormalities would be therapeutically effective. Results from this technique in ME/CFS patients still require validation and functional investigation to establish pathological significance.